IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 246 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,748,397 | +26.6% | 258,308 | +25.2% | 0.01% | +11.1% |
| Q1 2023 | $2,170,360 | +2.9% | 206,308 | +21.1% | 0.01% | -18.2% |
| Q4 2022 | $2,109,943 | +52.6% | 170,294 | +27.5% | 0.01% | +37.5% |
| Q3 2022 | $1,383,000 | -18.4% | 133,531 | -9.2% | 0.01% | -38.5% |
| Q2 2022 | $1,695,000 | +140.1% | 147,025 | +161.9% | 0.01% | +116.7% |
| Q1 2022 | $706,000 | -61.4% | 56,140 | -64.2% | 0.01% | -57.1% |
| Q4 2021 | $1,828,000 | +104.2% | 156,795 | +128.9% | 0.01% | +27.3% |
| Q3 2021 | $895,000 | +13.0% | 68,501 | -1.5% | 0.01% | 0.0% |
| Q4 2020 | $792,000 | +40.9% | 69,532 | +27.6% | 0.01% | +37.5% |
| Q2 2020 | $562,000 | +244.8% | 54,505 | +236.6% | 0.01% | +14.3% |
| Q1 2020 | $163,000 | 0.0% | 16,194 | +32.1% | 0.01% | +40.0% |
| Q4 2019 | $163,000 | – | 12,263 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |